Modified-release capsules containing sodium riboflavin 5′-phosphate

Abstract

Introduction: The focus of this work was to produce delayed-release capsules containing riboflavin (vitamin B₂, as API) layered pellets. Riboflavin therapy is indicated in patients with a riboflavin deficiency, which usually occurs in conjunction with malabsorption, alcoholism or a protein-calorie deficiency and rarely as the sole vitamin deficiency. Riboflavin is readily absorbed from the upper gastrointestinal tract by a specific transport mechanism. The dissolution rate of coated capsules was controlled through the coating of the capsules and the thickness of the coating layer.

Methods: The core pellets (Cellet 300) were loaded with a 10% aqueous solution of sodium riboflavin 5′-phosphate by a layering technique in a coating pan. Hard capsules were filled with riboflavin layered pellets and coated with Eudragit NE polymer with different coating layer thicknesses. The dissolution was tested in gastric and intestinal fluids with the half-change method. The dissolution profiles were analyzed with the use of different mathematical models and an attempt was made to predict the optimum coating film thickness that ensures the required degree and rate of dissolution.

Results: A new solid dosage form was developed which can enhance the bioavailability of riboflavin. RRSBW distribution and the Chapman–Richards growth function were used to fit the dissolution profiles. Statistical analysis indicated that the best products were described by the Chapman–Richards equation. The results were utilized to create a theoretical model suitable for prediction of the optimum film thickness that ensures the required release of riboflavin.

• Dissolution
• fitting
• hard capsule coating
• layering technique
• theoretical model